MetaCap

Aethlon Medical (AEMD) vs Fractyl Health (GUTS)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Fractyl Health is the larger company by market cap ($10.9 million vs $8.8 million), about 1.2 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

AEMD-10.05%GUTS-81.86%
+4%-41%-86%
Oct 7, 20261 yearNov 20, 2026
AEMD-9.75%GUTS-81.45%
+4%-41%-86%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

AEMD versus GUTS key metrics
MetricAEMDGUTS
Share price$5.46$0.82
Market cap$8.78M$10.88M
1-day change+12.81%-14.16%
YTD return—-96.89%
1-year return—-95.12%
EPS (TTM)$-16.22$-3.14
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$0
Revenue growth (YoY)—-100.00%
Net income (latest FY)$-7.15M$-140.95M
52-week high$24.75$29.34
52-week low$1.41$0.784
Distance from 52-week high-77.94%-97.21%
Analyst consensusnonestrong_buy
Avg. price target upside+142.67%+7265.85%
Average volume2.56M504.39K
Shares outstanding1.61M13.26M
Employees9100
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Aethlon Medical

AEMD stock →

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states.

Health Care · Medical/Dental Instruments · 9 employees

About Fractyl Health

GUTS stock →

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. It develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans.

Health Care · Medical/Dental Instruments · 100 employees

AEMD vs GUTS FAQ

Which is bigger, Aethlon Medical or Fractyl Health?

Fractyl Health (GUTS) is larger, with a market capitalization of $10.88M compared with $8.78M for Aethlon Medical (AEMD).

Are Aethlon Medical and Fractyl Health in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons